![]() [Full Bars] |
![]() [SiteTable] |
|
![]() [Back to Search Page] |
![]() [Back to HOMCOS] |
![]() [help] |
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100] | ![]() [show] [download] [help] |
PID | QueryLength | Homolgous Sequence in PDB | UniProt Query | TITLE |
14375 | 1273 | 500 | YP_009724390.1() | |
QUERYSEQ |
MFVFLVLLPLVSSQCVNLTTRTQLPPAYTNSFTRGVYYPDKVFRSSVLHSTQDLFLPFFSNVTWFHAIHVSGTNGTKRFDNPVLPFNDGVYFASTEKSNIIRGWIFGTTLDSKTQSLLIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNK SWMESEFRVYSSANNCTFEYVSQPFLMDLEGKQGNFKNLREFVFKNIDGYFKIYSKHTPINLVRDLPQGFSALEPLVDLPIGINITRFQTLLALHRSYLTPGDSSSGWTAGAAAYYVGYLQPRTFLLKYNENGTITDAVDCALDPLSETK CTLKSFTVEKGIYQTSNFRVQPTESIVRFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFKCYGVSPTKLNDLCFTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDFTGCVIAWNSNNLDSKVGGNYN YLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPYRVVVLSFELLHAPATVCGPKKSTNLVKNKCVNFNFNGLTGTGVLTESNKKFLPFQQFGRDIADTTDAVRDPQTLEILDITPCSFGGVSVITP GTNTSNQVAVLYQDVNCTEVPVAIHADQLTPTWRVYSTGSNVFQTRAGCLIGAEHVNNSYECDIPIGAGICASYQTQTNSPRRARSVASQSIIAYTMSLGAENSVAYSNNSIAIPTNFTISVTTEILPVSMTKTSVDCTMYICGDSTECS NLLLQYGSFCTQLNRALTGIAVEQDKNTQEVFAQVKQIYKTPPIKDFGGFNFSQILPDPSKPSKRSFIEDLLFNKVTLADAGFIKQYGDCLGDIAARDLICAQKFNGLTVLPPLLTDEMIAQYTSALLAGTITSGWTFGAGAALQIPFAM QMAYRFNGIGVTQNVLYENQKLIANQFNSAIGKIQDSLSSTASALGKLQDVVNQNAQALNTLVKQLSSNFGAISSVLNDILSRLDKVEAEVQIDRLITGRLQSLQTYVTQQLIRAAEIRASANLAATKMSECVLGQSKRVDFCGKGYHLM SFPQSAPHGVVFLHVTYVPAQEKNFTTAPAICHDGKAHFPREGVFVSNGTHWFVTQRNFYEPQIITTDNTFVSGNCDVVIGIVNNTVYDPLQPELDSFKEELDKYFKNHTSPDVDLGDISGINASVVNIQKEIDRLNEVAKNLNESLIDL QELGKYEQYIKWPWYIWLGFIAGLIAIVMVTIMLCCMTSCCSCLKGCCSCGSCCKFDEDDSEPVLKGVKLHYT |
1273 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
region | name | description |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
1-1273 | DISORDER | predicted by DISOPRED (1-26,679-687,1021-1021,1024-1024,1271-1273) |
![]() |
|||||||
1273 | |||||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
pdb_id | a1 | identity[%]2 | description | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 99.8 | SPIKE_SARS2 Spike glycoprotein | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | SPIKE_SARS2 Spike glycoprotein | |||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 100.0 | SPIKE_SARS2 Spike glycoprotein | |||
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue. |
![]() |
|||||||
1273 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CC12.3 light chain[213 aa] | A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Light chain of Fab domain of monoclonal antibody S.. | G | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
J | Light Chain of FC05 Fab[109 aa] | M | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | light chain of FC05 Fab[109 aa] | H | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | antibody heavy chain[220 aa] | C | 100.0 /100.0 |
20 /20 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CR3022 antibody[216 aa] | D | 100.0 /100.0 |
16 /16 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | CR3022 Fab Heavy Chain[213 aa] | D | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | CR3022 Fab Heavy Chain[213 aa] | D | 100.0 /100.0 |
12 /12 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Synthetic nanobody SR4[119 aa] | B | 100.0 /100.0 |
20 /20 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Light chain of H014 Fab[107 aa] | B | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | Light Chain of H014 Fab[107 aa] | M | 100.0 /100.0 |
8 /8 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CR3022 Fab Light Chain[202 aa] | C | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Synthetic nanobody MR17[120 aa] | B | 100.0 /100.0 |
18 /18 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Heavy chain of Fab domain of monoclonal antibody S.. | G | 100.0 /100.0 |
12 /12 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CC12.3 heavy chain[220 aa] | A | 100.0 /100.0 |
18 /18 |
SPIKE_SARS2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Heavy chain of Fab domain of monoclonal antibody S.. | G | 100.0 /100.0 |
13 /13 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | 52 Fab Heavy Chain[212 aa] | E | 100.0 /100.0 |
14 /14 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Light chain of Fab domain of monoclonal antibody S.. | G | 100.0 /100.0 |
13 /13 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | light chain of human antibody C1A-C2 Fab[214 aa] | A | 100.0 /100.0 |
12 /12 |
A0A6N1WIU8_SARS2 Surface glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | 52 Fab Light Chain[212 aa] | E | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | CB6 light chain[215 aa] | A | 100.0 /100.0 |
8 /8 |
SPIKE_SARS2 SARS-Cov-2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | S304 Fab light chain[212 aa] | A | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | EY6A light chain[215 aa] | A | 100.0 /100.0 |
13 /13 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | antibody light chain[213 aa] | C | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | EY6A light chain[215 aa] | A | 100.0 /99.8 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | EY6A light chain[215 aa] | G | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | heavy chain of FC05 Fab[120 aa] | G | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | Heavy Chain of FC05 Fab[120 aa] | M | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | heavy chain of P17 Fab[120 aa] | A | 100.0 /100.0 |
11 /11 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | IgG L chain[219 aa] | D | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | light chain[220 aa] | A | 100.0 /100.0 |
8 /8 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CR3022 Light chain[219 aa] | C | 100.0 /100.0 |
8 /8 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CR3022 Fab Light Chain[218 aa] | C | 100.0 /100.0 |
10 /10 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 298 Fab Light Chain[220 aa] | E | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | CR3022 Fab light chain[221 aa] | C | 100.0 /100.0 |
9 /9 |
SPIKE_SARS2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CB6 heavy chain[218 aa] | D | 100.0 /100.0 |
19 /19 |
SPIKE_SARS2 SARS-Cov-2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | ACE2_FELCA Angiotensin-converting enzyme 2[597 aa] | B | 100.0 /100.0 |
18 /18 |
SPIKE_SARS2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Nanobody H11-H4[128 aa] | C | 100.0 /99.8 |
14 /14 |
SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | H11-H4[128 aa] | A | 100.0 /100.0 |
14 /14 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | Nanobody H11-H4[128 aa] | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 WAC_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody[125 aa] | A | 100.0 /100.0 |
15 /15 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | Nanobody Nb20[117 aa] | A | 100.0 /100.0 |
12 /12 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 298 Fab Heavy Chain[218 aa] | E | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | CV30 Fab Heavy chain[219 aa] | C | 100.0 /100.0 |
19 /19 |
SPIKE_SARS2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | heavy chain[220 aa] | G | 100.0 /100.0 |
11 /11 |
SPIKE_SARS2 RBD |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | EY6A heavy chain[219 aa] | A | 100.0 /99.8 |
11 /11 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | EY6A heavy chain[219 aa] | C | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | EY6A heavy chain[219 aa] | D | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | COVA1-16 heavy chain[230 aa] | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Heavy chain of antibody C1A-B12 Fab[219 aa] | E | 100.0 /100.0 |
19 /19 |
A0A6N1WIU8_SARS2 Surface glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | The heavy chain of 3C1 fab that binds with the up .. | H | 100.0 /99.8 |
22 /22 |
SPIKE_SARS2 SARS-Cov2 S protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | The heavy chain of 3C1 fab that binds with the up .. | I | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-Cov2 S protein |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | The light chain of 3C1 fab[213 aa] | C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-Cov2 S protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | The light chain of 3C1 fab[213 aa] | H | 100.0 /99.8 |
19 /19 |
SPIKE_SARS2 SARC-CoV2 S protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | The light chain of 3C1 fab[180 aa] | I | 100.0 /99.8 |
17 /17 |
SPIKE_SARS2 SARS-Cov2 S protein |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | The light chain of 3C1 fab[213 aa] | B | 100.0 /99.8 |
7 /7 |
SPIKE_SARS2 SARS-Cov2-S protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | The heavy chain fragment of 2H2 Fab[214 aa] | D | 100.0 /99.8 |
14 /14 |
SPIKE_SARS2 SARS-CoV-2 S protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | The light chain fragment of 2H2 Fab[218 aa] | C | 100.0 /99.8 |
13 /13 |
SPIKE_SARS2 SARS-CoV-2 S protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | The light chain of 2H2 Fab[218 aa] | D | 100.0 /99.8 |
10 /10 |
SPIKE_SARS2 SARS-CoV-2 S protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | The light chain fragment of 2H2 Fab[119 aa] | I | 100.0 /99.8 |
8 /8 |
SPIKE_SARS2 SARS-CoV-2 S protein |
![]() ![]() ![]() ![]() ![]() |
![]() |
A | The heavy chain fragment of 2H2 Fab[18 aa] | I | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 S protein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Neutralising sybody (Sb23)[114 aa] | A | 100.0 /99.8 |
9 /9 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | Neutralising sybody (Sb23)[114 aa] | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | heavy chain of 4A8[229 aa] | C | 100.0 /99.8 |
11 /11 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Nanobody Ty1[118 aa] | B | 100.0 /99.8 |
18 /18 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | Nanobody Ty1[118 aa] | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | S2M11 Fab fragment (heavy chain)[122 aa] | A | 100.0 /99.8 |
14 /14 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | S2M11 Fab fragment (heavy chain)[122 aa] | D | 100.0 /99.8 |
7 /7 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | S2M11 Fab fragment (light chain)[105 aa] | D | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
C | S2M11 Fab fragment (light chain)[105 aa] | D | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 2-4 Heavy Chain[122 aa] | C | 100.0 /99.8 |
13 /13 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ACE2_HUMAN Angiotensin-converting enzyme 2[597 aa] | C | 53.8 /76.7 |
13 /13 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | ACE2_HUMAN Angiotensin-converting enzyme 2[588 aa] | B | 100.0 /100.0 |
15 /15 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ACE2_HUMAN Angiotensin-converting enzyme 2[595 aa] | A | 100.0 /99.8 |
18 /18 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | ACE2_HUMAN Angiotensin-converting enzyme 2[544 aa] | B | 42.1 /76.3 |
19 /19 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | ACE2_HUMAN Angiotensin-converting enzyme 2[596 aa] | B | 100.0 /100.0 |
19 /19 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | heavy chain of H014 Fab[122 aa] | B | 100.0 /100.0 |
16 /16 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Heavy Chain of H014 Fab[122 aa] | N | 100.0 /100.0 |
17 /17 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | Heavy chain of H014 Fab[214 aa] | C | 100.0 /99.8 |
8 /8 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | Heavy chain of H014 Fab[214 aa] | A | 100.0 /99.8 |
17 /17 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Light chain of H014 Fab[207 aa] | A | 100.0 /99.8 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
I | S304 Fab heavy chain[219 aa] | G | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | Heavy chain of Fab domain of monoclonal antibody S.. | G | 100.0 /100.0 |
13 /13 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | C121 Fab Heavy chain[128 aa] | B | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | C121 Fab Heavy chain[128 aa] | A | 100.0 /99.8 |
11 /11 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Synthetic nanobody Nb6[118 aa] | C | 100.0 /99.8 |
16 /16 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Synthetic nanobody mNb6[118 aa] | E | 100.0 /99.8 |
7 /7 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | C121 Fab Light chain[108 aa] | B | 100.0 /99.8 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | C121 Fab Light chain[108 aa] | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
H | C002 Fab Heavy Chain[125 aa] | C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | C002 Fab Heavy Chain[125 aa] | A | 100.0 /99.8 |
13 /13 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | light chain of P17 Fab[107 aa] | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | C002 Fab Light Chain[107 aa] | C | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | P17 light chain[108 aa] | B | 100.0 /100.0 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | Ab23-Fab-Heavy Chain[102 aa] | B | 100.0 /99.8 |
14 /14 |
SPIKE_SARS2 SARS-CoV-2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | autonomous human heavy chain variable domain[366 a.. | D | 100.0 /99.8 |
14 /14 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Light chain of Fab domain of monoclonal antibody S.. | G | 100.0 /100.0 |
9 /9 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
C | S2A4 Fab light chain[214 aa] | A | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | S2A4 Fab heavy chain[220 aa] | D | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | S2H13 Fab light chain[109 aa] | G | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | S2H13 Fab light chain[109 aa] | B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | S2H13 Fab heavy chain[118 aa] | A | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | S309 neutralizing antibody heavy chain[123 aa] | G | 100.0 /99.8 |
13 /13 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | S309 neutralizing antibody light chain[99 aa] | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | C104 Fab Heavy Chain[106 aa] | A | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | C119 Fab Light Chain[111 aa] | B | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | C119 Fab Light Chain[111 aa] | A | 100.0 /99.7 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | C119 Fab Heavy Chain[126 aa] | A | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | C119 Fab Heavy Chain[126 aa] | C | 100.0 /99.7 |
8 /8 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | C104 Fab Light Chain[107 aa] | A | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | C104 Fab Light Chain[107 aa] | B | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | C105 Fab Heavy Chain[116 aa] | B | 100.0 /99.7 |
13 /13 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | C105 Fab Light Chain[111 aa] | C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
I | A0A5C2GJG2_HUMAN 2-4 Light Chain[108 aa] | A | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | C110 Fab Heavy Chain[126 aa] | C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
E | C135 Fab Light Chain[106 aa] | A | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | C135 Fab Heavy Chain[118 aa] | A | 100.0 /99.7 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | BD-368-2 Fab light chain[112 aa] | B | 100.0 /99.4 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | C144 Fab Heavy Chain[129 aa] | A | 100.0 /99.4 |
12 /12 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | C144 Fab Heavy Chain[129 aa] | B | 100.0 /99.4 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
I | C144 Fab Light Chain[108 aa] | C | 100.0 /99.4 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | BD-368-2 Fab heavy chain[124 aa] | B | 100.0 /99.4 |
9 /9 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | S2E12 neutralizing antibody Fab fragment (heavy ch.. | A | 100.0 /99.4 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | CTC-445.2 inhibitor[160 aa] | C | 100.0 /99.4 |
15 /15 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | CTC-445.2 inhibitor[160 aa] | C | 100.0 /99.4 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
C | S2E12 neutralizing antibody Fab fragment (light ch.. | A | 100.0 /99.4 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | LCB1[55 aa] | E | 100.0 /99.4 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | LCB1[55 aa] | A | 100.0 /99.4 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | LCB1[55 aa] | C | 100.0 /99.4 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | LCB3[64 aa] | A | 100.0 /99.5 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
B | LCB3[64 aa] | C | 100.0 /99.4 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | S230 light chain[110 aa] | B | 0.0 /78.4 |
3 /3 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | S230 heavy chain[124 aa] | B | 100.0 /78.3 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | S230 heavy chain[123 aa] | C | 100.0 /77.7 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1273 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
PG0
|
D | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BB |
VCG
|
B | 100.0 /99.8 |
15 /15 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
EL |
PRO
|
C | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
JK |
PRO
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
ML |
PRO
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
BJ |
PRO
|
B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
RG |
PRO
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
WG |
PRO
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TA |
HIS
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FB |
NAG
|
C | 100.0 /77.7 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
UA |
NAG
|
D | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TA |
NAG
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
ZA |
NAG
|
C | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
SA |
NAG
|
C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
ZA |
NAG
|
C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TA |
NAG
|
D | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
NAG
|
C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
VA |
NAG
|
G | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
SA |
NAG
|
C | 100.0 /99.6 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
VA |
NAG
|
C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AB |
NAG
|
C | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
NAG
|
A | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
R |
NAG
|
A | 100.0 /99.6 |
3 /3 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
V |
NAG
|
C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
OA |
NAG
|
C | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V |
NAG
|
C | 100.0 /76.5 |
1 /1 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
NAG
|
C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA |
NAG
|
C | 100.0 /77.0 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
NAG
|
B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
NAG
|
A | 100.0 /99.6 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
NAG
|
B | 100.0 /76.5 |
3 /3 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P |
NAG
|
B | 50.0 /91.6 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
PA |
NAG
|
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AB |
NAG
|
C | 100.0 /97.4 |
1 /1 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
MA |
NAG
|
A | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
WA |
NAG
|
C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
NAG
|
A | 50.0 /76.5 |
2 /2 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FB |
NAG
|
G | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
NAG
|
B | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
X |
NAG
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
YA |
NAG
|
A | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
PA |
NAG
|
D | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TA |
NAG
|
C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
NAG
|
B | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
NAG
|
D | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
NAG
|
A | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
V |
NAG
|
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
NAG
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
QA |
NAG
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
NAG
|
C | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R |
NAG
|
C | 100.0 /91.6 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GB |
NAG
|
C | 100.0 /97.4 |
1 /1 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
NAG
|
D | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
NAG
|
A | 50.0 /76.5 |
2 /2 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA |
NAG
|
C | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
NAG
|
B | 100.0 /76.5 |
3 /3 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
NAG
|
C | 100.0 /76.8 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
NAG
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
NAG
|
B | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
NAG
|
B | 100.0 /76.5 |
1 /1 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X |
NAG
|
A | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
NAG
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TA |
NAG
|
C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
BA |
NAG
|
A | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
WA |
NAG
|
A | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
NAG
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
NAG
|
A | 50.0 /91.6 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
U |
NAG
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA |
NAG
|
A | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
YA |
NAG
|
A | 50.0 /77.9 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
NAG
|
A | 100.0 /91.6 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA |
NAG
|
B | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DB |
NAG
|
B | 100.0 /78.3 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CB |
NAG
|
B | 100.0 /78.4 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
NAG
|
A | 100.0 /91.6 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
NAG
|
B | 100.0 /76.5 |
3 /3 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
NAG
|
C | 50.0 /76.5 |
2 /2 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
NAG
|
A | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
VA |
NAG
|
C | 100.0 /97.4 |
1 /1 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
V |
NAG
|
A | 100.0 /99.6 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
VA |
NAG
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA |
NAG
|
A | 0.0 /76.5 |
1 /1 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA |
NAG
|
B | 0.0 /76.5 |
1 /1 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA |
NAG
|
A | 50.0 /76.5 |
4 /4 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
EA |
NAG
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
JA |
NAG
|
C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
YK |
GLN
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
YK |
GLN
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
DL |
GLN
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
YN |
ILE
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WK |
ILE
|
C | 100.0 /99.7 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
QN |
ILE
|
C | 100.0 /99.7 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IL |
ILE
|
C | 100.0 /99.7 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
FQ |
ILE
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
EO |
ILE
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
XG |
ILE
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TO |
ILE
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
NM |
ILE
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
XL |
VAL
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JN |
VAL
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
GM |
VAL
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JL |
VAL
|
C | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
RA |
VAL
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CL |
VAL
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
RM |
VAL
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
EP |
VAL
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
MA |
VAL
|
B | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
SK |
VAL
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
DP |
LYS
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
VI |
LYS
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
DJ |
LYS
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
LYS
|
B | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
UK |
LYS
|
C | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
VO |
TRP
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
NK |
THR
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
BM |
THR
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
HN |
THR
|
C | 100.0 /99.7 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
J |
THR
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
FL |
THR
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
UE |
THR
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
PO |
THR
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
RK |
THR
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
DQ |
THR
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
UI |
PHE
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
OO |
PHE
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
VE |
PHE
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA |
PHE
|
B | 100.0 /99.8 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
ON |
PHE
|
C | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
YL |
PHE
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
PP |
PHE
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BL |
PHE
|
C | 100.0 /99.7 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GN |
PHE
|
C | 100.0 /99.7 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LL |
PHE
|
C | 100.0 /99.7 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
UN |
GLU
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TK |
GLU
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
QG |
GLU
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GL |
GLU
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
EQ |
GLU
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
LP |
LEU
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
OP |
LEU
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
KK |
LEU
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
BN |
LEU
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
EN |
LEU
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
AP |
LEU
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
NP |
ARG
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
OA |
ARG
|
B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RN |
ARG
|
C | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
CM |
ARG
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KL |
ARG
|
C | 100.0 /99.7 |
11 /11 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
ARG
|
A | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
ARG
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
KA |
ASP
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BP |
ASP
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TN |
ASP
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TM |
ASP
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
MN |
ASP
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
PM |
ASN
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
PM |
ASN
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
NL |
ASN
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
KI |
ASN
|
B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
WO |
ASN
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
ASN
|
A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
ASN
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
HP |
ASN
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
CN |
ASN
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
IN |
ASN
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
BG |
TYR
|
B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
XK |
TYR
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
HM |
TYR
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
PI |
TYR
|
B | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
JO |
TYR
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
TYR
|
B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1273 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CL
|
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1273 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | B | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-.. | B | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | alpha-L-fucopyranose-(1-3)-[2-acetamido-2-deoxy-be.. | B | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
HA | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | B | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
W | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
X | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | C | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | B | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | C | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | B | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
LA | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | C | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
KA | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | C | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-be.. | A | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
P | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /97.4 |
1 /1 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
AA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
3 /3 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.4 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
N | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.9 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 80.0 /76.2 |
5 /5 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
P | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | D | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 75.0 /76.8 |
4 /4 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
O | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 50.0 /76.2 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
CA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
GA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() |
![]() |
X | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | G | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 0.0 /76.3 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /97.4 |
5 /5 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
EA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /76.3 |
4 /4 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
W | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /97.4 |
1 /1 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /97.4 |
3 /3 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /78.3 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /76.2 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /97.4 |
3 /3 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike protein S1 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
I | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | G | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /97.4 |
4 /4 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
S | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /78.1 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
N | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
KA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 0.0 /77.8 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | A | 100.0 /76.2 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
P | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /76.3 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | C | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
S | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | B | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | B | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
GB | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | D | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | B | 100.0 /97.4 |
2 /2 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
GB | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | F | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[al.. | C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() |
![]() |
T | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | B | 100.0 /99.8 |
2 /2 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-a.. | C | 100.0 /99.8 |
3 /3 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | C | 75.0 /76.3 |
4 /4 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | B | 100.0 /76.3 |
3 /3 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
L | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
DA | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | B | 60.0 /78.3 |
5 /5 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | B | 100.0 /78.4 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
L | alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(.. | B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | D | 100.0 /99.8 |
5 /5 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Q | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 85.7 /76.3 |
7 /7 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /77.7 |
3 /3 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /77.8 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /77.9 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
CA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 80.0 /76.3 |
5 /5 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 0.0 /78.3 |
1 /1 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 33.3 /77.1 |
3 /3 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
G | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 0.0 /76.3 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
BA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /97.4 |
3 /3 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 50.0 /78.1 |
4 /4 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /77.8 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
N | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /76.3 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /76.3 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /76.3 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 75.0 /76.2 |
4 /4 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
IA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 50.0 /77.9 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /78.3 |
3 /3 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
FA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 50.0 /77.7 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
K | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 SARS-CoV-2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Z | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | B | 100.0 /78.3 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
JA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 50.0 /78.1 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
TA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /78.1 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /76.3 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 50.0 /77.0 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
K | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 SARS-CoV-2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 50.0 /77.7 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | A | 100.0 /99.8 |
5 /5 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
HC | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
TA | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | D | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
V | beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-bet.. | C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
GA | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | C | 100.0 /97.4 |
1 /1 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 66.7 /97.4 |
3 /3 |
A0A6B9WHD3_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
J | alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-bet.. | A | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
T | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 75.0 /77.8 |
4 /4 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 100.0 /76.3 |
3 /3 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 80.0 /77.1 |
5 /5 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
X | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 100.0 /76.2 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
U | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | C | 100.0 /99.8 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 80.0 /76.2 |
5 /5 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 50.0 /76.3 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
F | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 100.0 /99.8 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 100.0 /77.1 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | B | 50.0 /76.3 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
R | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | C | 60.0 /76.2 |
5 /5 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() |
![]() |
O | alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(.. | A | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
BA | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | B | 75.0 /78.3 |
4 /4 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 75.0 /76.2 |
4 /4 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
P | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 75.0 /77.9 |
4 /4 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
U | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /77.8 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RA | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | C | 75.0 /77.7 |
4 /4 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 100.0 /77.9 |
2 /2 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | A | 75.0 /76.2 |
4 /4 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | B | 0.0 /76.3 |
1 /1 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
S | alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose.. | C | 100.0 /76.3 |
2 /2 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1273 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[348 aa] | B | 100.0 /100.0 |
120 /120 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike glycoprotein[972 aa] | C | 100.0 /99.9 |
96 /96 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike glycoprotein[1098 aa] | C | 100.0 /99.8 |
94 /94 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SPIKE_SARS2 SARS-CoV-2 spike glycoprotein[1034 aa] | G | 100.0 /99.8 |
86 /86 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O | SPIKE_SARS2 Spike glycoprotein[1076 aa] | M | 100.0 /100.0 |
78 /78 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[1017 aa] | C | 98.6 /99.8 |
72 /72 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 SARS-CoV-2 Spike glycoprotein[1029 aa] | A | 98.3 /99.2 |
115 /115 |
SPIKE_SARS2 SARS-CoV-2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | PTPRS_CHICK SPIKE_SARS2 WAC_BPT4 Receptor-type tyrosine-protein phosphatase S,Spike.. | A | 100.0 /99.8 |
74 /74 |
PTPRS_CHICK SPIKE_SARS2 WAC_BPT4 Receptor-type tyrosine-protein phosphatase S,Spike.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G | SPIKE_SARS2 SARS-CoV-2 spike glycoprotein[977 aa] | A | 100.0 /99.8 |
93 /93 |
SPIKE_SARS2 SARS-CoV-2 spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
F | SPIKE_SARS2 Spike glycoprotein[1108 aa] | A | 100.0 /99.8 |
9 /9 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[1120 aa] | F | 100.0 /99.8 |
12 /12 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | PTPRS_CHICK SPIKE_SARS2 WAC_BPT4 Receptor-type tyrosine-protein phosphatase S,Spike.. | C | 100.0 /99.8 |
82 /82 |
PTPRS_CHICK SPIKE_SARS2 WAC_BPT4 Receptor-type tyrosine-protein phosphatase S,Spike.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | PTPRS_CHICK SPIKE_SARS2 WAC_BPT4 Receptor-type tyrosine-protein phosphatase S,Spike.. | B | 100.0 /99.8 |
72 /72 |
PTPRS_CHICK SPIKE_SARS2 WAC_BPT4 Receptor-type tyrosine-protein phosphatase S,Spike.. |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike glycoprotein[602 aa] | B | 100.0 /99.8 |
77 /77 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike glycoprotein[602 aa] | A | 100.0 /99.8 |
77 /77 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[801 aa] | B | 100.0 /99.8 |
80 /80 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[801 aa] | C | 100.0 /99.8 |
73 /73 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SPIKE_SARS2 Spike glycoprotein[188 aa] | C | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D | SPIKE_SARS2 Spike glycoprotein[188 aa] | A | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike protein S1, Spike protein S2[1010 aa] | A | 100.0 /99.8 |
63 /63 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike protein S1, Spike protein S2[1010 aa] | C | 100.0 /99.7 |
63 /63 |
SPIKE_SARS2 Spike protein S1, Spike protein S2 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_SARS2 Spike glycoprotein[785 aa] | A | 100.0 /99.6 |
58 /58 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_SARS2 Spike glycoprotein[785 aa] | B | 100.0 /99.6 |
55 /55 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike glycoprotein[787 aa] | A | 100.0 /99.6 |
58 /58 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_SARS2 Spike glycoprotein[787 aa] | B | 100.0 /99.6 |
53 /53 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_CVHSA Spike glycoprotein[344 aa] | B | 95.6 /91.6 |
114 /114 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_CVHSA Spike glycoprotein[736 aa] | A | 85.1 /81.9 |
47 /47 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_CVHSA Spike glycoprotein[736 aa] | B | 94.0 /81.9 |
50 /50 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[893 aa] | B | 83.3 /76.3 |
72 /72 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[893 aa] | A | 91.9 /77.1 |
62 /62 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[891 aa] | B | 90.6 /76.3 |
64 /64 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[891 aa] | C | 85.5 /77.0 |
69 /69 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[881 aa] | B | 90.0 /76.8 |
70 /70 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin[881 aa] | A | 84.2 /76.8 |
76 /76 |
SPIKE_CVHSA D9IEJ2_BPT4 Spike glycoprotein,Fibritin |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
A | Spike glycoprotein[1033 aa] | B | 91.9 /76.5 |
74 /74 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
B | SPIKE_CVHSA Spike glycoprotein[1065 aa] | C | 86.5 /76.7 |
96 /96 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | Spike glycoprotein[1052 aa] | B | 88.2 /76.5 |
110 /110 |
Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_CVHSA Spike glycoprotein[1048 aa] | A | 91.5 /77.8 |
47 /47 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_CVHSA Spike glycoprotein[1065 aa] | B | 88.3 /76.7 |
94 /94 |
SPIKE_CVHSA Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
C | SPIKE_CVHSA Spike glycoprotein[1048 aa] | B | 88.9 /78.4 |
45 /45 |
SPIKE_CVHSA Spike glycoprotein |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. | |||||||
![]() |
|||||||
1273 | pdb_id | contact mol | homologue | ||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
a3 | description | a4 | identity[%]5 | Ncon6 | description | |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
B | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
D |
GOL
|
B | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
C |
GOL
|
B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
GOL
|
B | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
GOL
|
B | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
H |
GOL
|
B | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
GOL
|
B | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
GOL
|
B | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
I |
GOL
|
B | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
MLI
|
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
N |
MLI
|
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
P |
EDO
|
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
D |
EDO
|
A | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
H |
EDO
|
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
Q |
EDO
|
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
I |
EDO
|
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
N |
EDO
|
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
EDO
|
A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EDO
|
A | 100.0 /100.0 |
7 /7 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
EDO
|
A | 100.0 /100.0 |
6 /6 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
O |
EDO
|
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
DMS
|
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
DMS
|
A | 100.0 /99.8 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
NA |
DMS
|
A | 100.0 /99.8 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
T |
DMS
|
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
G |
DMS
|
A | 100.0 /100.0 |
5 /5 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
J |
DMS
|
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
Y |
DMS
|
D | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
LA |
DMS
|
A | 100.0 /99.8 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
IA |
DMS
|
D | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
K |
ACT
|
A | 100.0 /100.0 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
L |
ACT
|
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
F |
CAC
|
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
E |
CAC
|
A | 100.0 /100.0 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
W |
EIC
|
B | 100.0 /100.0 |
9 /9 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
W |
EIC
|
C | 100.0 /100.0 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
M |
EIC
|
A | 100.0 /100.0 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
RA |
EIC
|
A | 100.0 /99.8 |
15 /15 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
QA |
EIC
|
B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
QM |
CYS
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
RO |
CYS
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
WI |
CYS
|
B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
CQ |
SER
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
AJ |
SER
|
B | 100.0 /99.8 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
XO |
SER
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
NN |
SER
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
AL |
SER
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
OM |
SER
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
CP |
SER
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
HL |
SER
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
SM |
ALA
|
C | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
LN |
ALA
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
AM |
ALA
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
![]() |
VK |
GLY
|
C | 100.0 /99.7 |
4 /4 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
GP |
GLY
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
SN |
GLY
|
C | 100.0 /99.7 |
3 /3 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
QO |
GLY
|
C | 100.0 /99.7 |
2 /2 |
SPIKE_SARS2 Spike glycoprotein |
![]() ![]() ![]() ![]() ![]() |
![]() |
FP |
GLY
|
C | 100.0 /99.7 |
1 /1 |
SPIKE_SARS2 Spike glycoprotein |
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue. |